The global hypoparathyroidism treatment market share analysis is poised to achieve a significant milestone, reaching USD 785.7 million in sales by 2025. The increasing prevalence of hypoparathyroidism, advancements in drug development, and strategic initiatives by leading pharmaceutical companies are fueling market expansion. The competitive landscape is witnessing dynamic shifts as established players and emerging biotech …